Epidemiology of congenital toxoplasmosis identified by population-based newborn screening in Massachusetts

被引:22
作者
Jara, M [1 ]
Hsu, HW
Eaton, RB
Demaria, A
机构
[1] Massachusetts Dept Publ Hlth, Bur Commun Dis Control, Jamaica Plain, MA USA
[2] Univ Massachusetts, Sch Med, New England Newborn Screening Program, Jamaica, NY USA
关键词
congenital toxoplasmosis; epidemiology; neonatal screening; vital statistics;
D O I
10.1097/00006454-200112000-00007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Fourteen years of newborn screening in Massachusetts for congenital toxoplasmosis infection identified subpopulations that appeared to have higher rates of infection. Elaborating an epidemiologic profile and risk correlates might aid implementing targeted prenatal education and newborn screening strategies with the goal of early postnatal treatment to prevent morbidity. Objective. To describe the epidemiology of congenital toxoplasmosis in Massachusetts and risk correlates of infection using birth certificate data. Methods. A case-control study was conducted based on Massachusetts birth certificate data. Cases were all infants with congenital toxoplasmosis identified by statewide universal newborn screening from 1988 to 1999. Controls were all children born on the same day as those infants in Massachusetts. Results. Factors that strongly predicted congenital toxoplasmosis infection were mother's country of birth outside the US (especially the southeast Asian refugee origin countries of Cambodia and Laos), mother's educational level and higher gravidity. Conclusions. More extensive, culturally and linguistically appropriate, prenatal education is needed for pregnant women, regardless of a mother's educational level, especially for non-US-born mothers, and not focused only on primiparous women. Other states may be able to use their state-specific birth certificate data to compare risk profiles with those of Massachusetts to guide a toxoplasmosis screening policy on the basis of population similarities and differences.
引用
收藏
页码:1132 / 1135
页数:4
相关论文
共 10 条
[1]   Sources of toxoplasma infection in pregnant women: European multicentre case-control study [J].
Cook, AJC ;
Gilbert, RE ;
Buffolano, W ;
Zufferey, J ;
Petersen, E ;
Jenum, PA ;
Foulon, W ;
Semprini, AE ;
Dunn, DT .
BRITISH MEDICAL JOURNAL, 2000, 321 (7254) :142-147
[2]   INUTERO TREATMENT OF TOXOPLASMIC FETOPATHY WITH THE COMBINATION PYRIMETHAMINE-SULFADIAZINE [J].
COUVREUR, J ;
THULLIEZ, P ;
DAFFOS, F ;
AUFRANT, C ;
BOMPARD, Y ;
GESQUIERE, A ;
DESMONTS, G .
FETAL DIAGNOSIS AND THERAPY, 1993, 8 (01) :45-50
[3]   NEONATAL SEROLOGIC SCREENING AND EARLY TREATMENT FOR CONGENITAL TOXOPLASMA-GONDII INFECTION [J].
GUERINA, NG ;
HSU, HW ;
MEISSNER, HC ;
MAGUIRE, JH ;
LYNFIELD, R ;
STECHENBERG, B ;
ABROMS, I ;
PASTERNACK, MS ;
HOFF, R ;
EATON, RB ;
GRADY, GF ;
CHEESEMAN, SH ;
MCINTOSH, K ;
MEDEARIS, DN ;
ROBB, R ;
WEIBLEN, BJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (26) :1858-1863
[4]   COST-BENEFIT-ANALYSIS OF SCREENING FOR TOXOPLASMOSIS DURING PREGNANCY [J].
LAPPALAINEN, M ;
SINTONEN, H ;
KOSKINIEMI, M ;
HEDMAN, K ;
HIILESMAA, V ;
AMMALA, P ;
TERAMO, K ;
KOSKELA, P .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1995, 27 (03) :265-272
[5]   Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment [J].
Lebech, M ;
Andersen, O ;
Christensen, NC ;
Hertel, J ;
Nielsen, HE ;
Peitersen, B ;
Rechnitzer, C ;
Larsen, SO ;
Norgaard-Pedersen, B ;
Petersen, E .
LANCET, 1999, 353 (9167) :1834-1837
[6]   Is routine antenatal toxoplasmosis screening justified in the United States? Statistical considerations in the application of medical screening tests [J].
Mittendorf, R ;
Pryde, P ;
Herschel, M ;
Williams, MA .
CLINICAL OBSTETRICS AND GYNECOLOGY, 1999, 42 (01) :163-173
[7]   Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots [J].
Paul, M ;
Petersen, E ;
Pawlowski, ZS ;
Szczapa, J .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (01) :30-36
[8]  
*SAS I INC, 1996, SAS US GUID VERS 6 1
[9]  
STRAYPEDERSEN B, 1992, SCAND J INFECT DIS, P86
[10]  
WALLON M, 1993, BRIT MED J, V318, P1511